Table 1. Demographic characteristics of extensively drug resistant tuberculosis (XDR-TB) patients initiated on XDR-TB therapy during study period.
| XDR-TB Patients (% total) |
||
|---|---|---|
| Sex | Male | 26 (43) |
| Female | 34 | |
| Age (years) | <20 | 3 (5) |
| 20-35 | 28 (47) | |
| 36-50 | 24 (40) | |
| >50 | 6 (10) | |
| Median Age | 35.0 | |
| (S.D.) | (11.6) | |
| HIV Status | Positive | 43 (72) |
| Negative | 12 | |
| Unknown | 5 | |
| CD4 Count (cells/mm3) | Known | 29 (48) |
| Not Determined | 14 | |
| Median CD4 Count | 200.5 | |
| (S.D.) | (127.4) | |
| On HAART* | Yes | 21 (35) |
| No | 22 | |
| Adverse Events | Yes | 31 (52) |
| Severe† | 17 | |
| No | 20 | |
| Unknown | 9 | |
| Previous TB Treatment | Yes | 42 (70) |
| No | 11 | |
| Unknown | 7 | |
| Previous MDR-TB** Treatment | Yes | 22 (37) |
| No | 28 | |
| Unknown | 10 | |
| Health Care Worker | Yes | 3 (5) |
| No | 57 | |
| Type of Tuberculosis | Pulmonary | 43 (72) |
| Extrapulmonary | 8 | |
| Unknown | 9 | |
*
HAART – Highly active antiretroviral therapy
**
MDR-TB – Multi drug resistant tuberculosis
†
Severe Adverse Drug Reactions- resulted in significant change in clinical status, significant electrolyte abnormalities or required a change of anti-tuberculosis regimen.